We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SHL market cap is 13.22B. The company's latest EPS is AUD 1.0639 and P/E is 25.63.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 6.82B | 8.75B | 9.33B | 8.15B | 8.97B |
| Operating Income | 799.84M | 1.91B | 2.15B | 999.59M | 852.48M |
| Net Income | 527.75M | 1.32B | 1.46B | 684.98M | 511.09M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 12.13B | 11.76B | 12.55B | 13.01B | 14.83B |
| Total Liabilities | 6.46B | 5.26B | 5.12B | 5.09B | 6.75B |
| Total Equity | 5.66B | 6.5B | 7.43B | 7.92B | 8.08B |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 1.36B | 2.04B | 2.23B | 1.47B | 1.07B |
| Investing | -334.92M | -386.75M | -989.18M | -580.04M | -1.81B |
| Financing | -536.74M | -1.95B | -1.35B | -911.51M | 592.41M |
| Market Cap | 13.22B |
| Price to Earnings Ratio | 25.63 |
| Price to Sales Ratio | 1.46 |
| Price to Cash Ratio | 20.31 |
| Price to Book Ratio | 1.62 |
| Dividend Yield | 3.82% |
| Shares Outstanding | 480.4M |
| Average Volume (1 week) | 1.26M |
| Average Volume (1 Month) | 1.05M |
| 52 Week Change | -13.24% |
| 52 Week High | 36.51 |
| 52 Week Low | 21.00 |
| Spread (Intraday) | 0.03 (0.11%) |
| Company Name | Sonic Healthcare Limited |
| Address |
level 22 north sydney, new south wales 2000 |
| Website | https://www.sonichealthcare.com.au |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
